DUBLIN--(BUSINESS WIRE)--The "Autoimmune Disease Diagnosis - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Autoimmune Disease Diagnosis Market to Reach $6.9 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Autoimmune Disease Diagnosis estimated at US$4.3 Billion in the year 2022, is projected to reach a revised size of US$6.9 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2022-2030.
Consumables & Assay Kits, one of the segments analyzed in the report, is projected to record 6.6% CAGR and reach US$4.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 5.7% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 10.2% CAGR
The Autoimmune Disease Diagnosis market in the U.S. is estimated at US$1.2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 10.2% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.3% and 6.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.
Looking Ahead to 2023
Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year.
Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
What`s New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Autoimmune Disease Diagnosis Market: Prelude
- Global Autoimmune Disease Diagnosis Market: Percentage Breakdown of Revenues by End-Use Segment for 2019
- Global Systemic Autoimmune Disease Diagnostics Market: Percentage Breakdown of Revenues by Type for 2019
- Autoimmune Disease Diagnosis - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
FOCUS ON SELECT PLAYERS (Total 42 Featured)
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Euroimmun AG
- Grifols International SA
- Hycor Biomedical, Inc.
- INOVA Diagnostics, Inc.
- Protagen AG
- Siemens AG
- Thermo Fisher Scientific, Inc.
- Trinity Biotech PLC
MARKET TRENDS & DRIVERS
- Rising Incidence and Huge Economic Burden of Autoimmune Disorders Drives Focus onto Autoimmune Disease Diagnosis
- Statistics on Select Autoimmune Diseases
- Rheumatoid Arthritis
- Global Rheumatoid Arthritis Prevalence: Number of Prevalent RA Cases among Adults in Select Countries for the Years 2015 and 2025
- Arthritis in the US: Number of Adults with Doctor-Diagnosed Arthritis for the Years 2015, 2020, 2025, 2030, 2035, 2040
- Systemic Lupus Erythematosus
- Thyroiditis
- Scleroderma
- Increase in Healthcare Spending Worldwide Augurs Well for Autoimmune Diagnosis Market
- Global Healthcare Outlook: Spending in US$ Billion for 2017 and 2022
- Global Healthcare Spending: Top Countries Ranked by Public Health Spending Per Capital (in $) and Share of GDP Spent on Public Health
- Evolving Autoimmune Diagnostics Space, Automation of Autoimmunology Lab and Reduced Turnaround Times: Changes with Positive Implications for the Market
- Antinuclear Autoantibodies (ANA) Blood Test: Enabling Diagnosis of Autoimmune Diseases
- Developments in ANA Testing Facilitate Detection of Systemic Autoimmune Rheumatic Diseases
- Lab Testing for Autoimmune Diseases: Continuous Developments Aid in Improving Diagnosis Capabilities
- Multiplex Flow Immunoassay Emerges as a High Performance Technique for ANA Screening for Autoimmune Diseases
- RNA Testing for Diagnosis of Autoimmune Disease: A Faster and Accurate Method
- AVISE CTD: New Blood Test for Lupus Diagnosis
- PRODUCT OVERVIEW
- Autoimmune Diseases
- Diagnosis of Autoimmune Diseases
For more information about this report visit https://www.researchandmarkets.com/r/kifco0
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
